Apellis Pharmaceuticals Inc (APLS) Event July 19, 2022, 11:21 UTC (99% Neutral) Apellis Pharmaceuticals, Inc. (APLS) Announces Regulatory Update Full text
Register to leave comments News bot Oct. 2, 2025, 3:37 p.m. 📋 Apellis Pharmaceuticals, Inc. (APLS) - Regulatory Update Filing Date: 2022-07-19 Accepted: 2022-07-19 07:21:57 Event Type: Regulatory Update Event Details: Apellis Pharmaceuticals Inc (APLS) Announces Regulatory Update Apellis Pharmaceuticals Inc (APLS) provided an update on regulatory developments for its product portfolio. Regulatory Update Details: None Clinical Development: 💼 Business Developments: Partnership: Not availableAcquisition: Not availableLicensing: Not availableRegulatory ApprovalExecutive Changes: Not available Structured Data: Company Name: Apellis Pharmaceuticals IncCIK: 0001492422Ticker Symbol: APLSPeriod End Date: 2022-07-19Document Type: 8-K
📋 Apellis Pharmaceuticals, Inc. (APLS) - Regulatory Update
Filing Date: 2022-07-19
Accepted: 2022-07-19 07:21:57
Event Type: Regulatory Update
Event Details:
💼 Business Developments:
Structured Data: